Galactosylation of serum IgA1 O-glycans in celiac disease

Journal of Clinical Immunology

Volumn 31, Issue 1, 2011, Pages 74-79

  Lindfors, Katri ^a   Suzuki, Hitoshi ^b,c   Novak, Jan ^b   Collin, Pekka ^d   Saavalainen, Päivi ^e   Koskinen, Lotta L E ^e   Mäki, Markku ^a   Kaukinen, Katri ^a,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b University of Alabama at Birmingham   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

anti transglutaminase 2 autoantibody; Celiac disease; galactose deficiency; gluten; IgA1

Indexed keywords

AUTOANTIBODY; GALACTOSE; GLYCAN DERIVATIVE; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ABDOMINAL DISEASE; ADULT; AGED; ANEMIA; ANTIBODY TITER; ARTICLE; AUTOIMMUNE THYROIDITIS; BLOOD SAMPLING; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROSCOPY; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; MALABSORPTION; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CELIAC DISEASE; DIET, GLUTEN-FREE; FEMALE; GALACTOSE; GLYCOSYLATION; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; POLYSACCHARIDES; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 79953858140     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9473-7     Document Type: Article

References (28)

1. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2:647-55. (Pubitemid 37328722)
2. Heap GA, van Heel DA. Genetics and pathogenesis of coeliac disease. Semin Immunol. 2009;21:346-54.
3. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797-801. (Pubitemid 27298728)
4. Niveloni S, Sugai E, Cabanne A, Vazquez H, Argonz J, Smecuol E, et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem. 2007;53:2186-92. (Pubitemid 350197303)
5. Kaukinen K, Collin P, Laurila K, Kaartinen T, Partanen J, Mäki M. Resurrection of gliadin antibodies in coeliac disease. deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol. 2007;42:1428-33. (Pubitemid 350125555)
6. Lindfors K, Mäki M, Kaukinen K. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease? Amino Acids. 2009;36:685-91.
7. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, Lebreton C, Ménard S, Candalh C, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med. 2008;205:143-54. (Pubitemid 351185722)
8. Julian B, Novak J. IgA nephropathy: an update. Curr Opin Nephrol Hypertens. 2004;13:171-9. (Pubitemid 38373139)
9. Collin P, Syrjänen J, Partanen J, Pasternack A, Kaukinen K, Mustonen J. Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol. 2002;97:2572-6.
10. Novak J, Julian BA, Tomana M, Mesteck J. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol. 2001;21:310-27. (Pubitemid 33015802)
11. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104:73-81. (Pubitemid 29534347)
12. Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol. 2004;15:622-34. (Pubitemid 38294792)
13. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007;71:1148-54. (Pubitemid 46809135)
14. Czerkinsky C, Koopman WJ, Jackson S, Collins JE, Crago SS, Schrohenloher RE, et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest. 1986;77:1931-8. (Pubitemid 16062650)
15. Coppo R, Basolo B, Piccoli G, Mazzucco G, Bulzomì MR, Roccatello D, et al. IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol. 1984;57:583-90. (Pubitemid 14057714)
16. Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy. Clin Exp Immunol. 1989;77:15-20. (Pubitemid 19198805)
17. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008;118:629-39. (Pubitemid 351206552)
18. Cremata JA, Sorell L, Montesino R, Garcia R, Mata M, Cabrera G, et al. Hypogalactosylation of serum IgG in patients with coeliac disease. Clin Exp Immunol. 2003;133:422-9. (Pubitemid 37046968)
19. Holopainen P, Mustalahti K, Uimari P, Collin P, Mäki M, Partanen J. Candidate gene regions and genetic heterogeneity in gluten sensitivity. Gut. 2001;48:696-701. (Pubitemid 32378593)
20. Royle L, Roos A, Harvey DJ, Wormald MR, van Gijlswijk-Janssen D, Redwan el-RM, et al. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem. 2003;278:20140-53. (Pubitemid 36799209)
21. Wold AE, Mestecky J, Svanborg Edén C. Agglutination of E. coli by secretory IgA - a result of interaction between bacterial mannose-specific adhesins and immunoglobulin carbohydrate? Monogr Allergy. 1988;24:307-9.
22. Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, Endo T, et al. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun. 1990;58:3073-7. (Pubitemid 20267705)
23. Mestecky J, Russell MW. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol Lett. 2009;124:57-62.
24. Forsberg G, Fahlgren A, Hörstedt P, Hammarström S, Hernell O, Hammarström ML. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol. 2004;99:894-904. (Pubitemid 39090220)
25. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 2007;56:1669-74. (Pubitemid 350276518)
26. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62:264-9.
27. Smith AC, Molyneux K, Feehally J, Barratt J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol. 2006;17:3520-8. (Pubitemid 44865295)
28. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 2008;19:1008-14.